Efficacy and safety of dose-dense neoadjuvant chemotherapy with nab-paclitaxel followed by epirubicin and cyclophosphamide for operable breast cancer.

Akiko Matsumoto,Hiromitsu Jinno,Saki Naruse,Yuka Isono,Yuka Maeda,Ayana Sato,Miki Yamada,Tatsuhiko Ikeda,Yuko Sasajima

Japanese journal of clinical oncology（2023）

引用 0|浏览1

暂无评分

摘要

Neoadjuvant dose-dense biweekly nanoparticle albumin-bound paclitaxel followed by dose-dense epirubicin and cyclophosphamide was effective, especially in patients with triple-negative disease, and feasible with pegfilgrastim support.

查看译文

关键词

breast neoplasms,neoadjuvant therapy,peripheral nervous system diseases

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要